Breakpoint to MIC quotient: A parameter to rapidly evaluate the in vitro bactericidal activity of β-lactams on Enterobacteriaceae.

Breakpoint to MIC quotient Enterobacteriaceae Etest European Committee on Antimicrobial Susceptibility Testing Minimum Bactericidal Concentration Minimum Inhibitory Concentration

Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
May 2019
Historique:
received: 10 12 2018
revised: 23 01 2019
accepted: 27 01 2019
pubmed: 5 2 2019
medline: 9 8 2019
entrez: 5 2 2019
Statut: ppublish

Résumé

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) do not completely predict the bactericidal nature of the antimicrobial agent. Patients with pathogens having MICs near the clinical breakpoint experience a higher risk of clinical failure. This study defined an indicator, breakpoint to MIC quotient (BMQ), that incorporates MIC and the European Committee on Antimicrobial Susceptibility Testing breakpoint. The BMQ was inversely correlated with MBC in antibiotic combinations against Enterobacteriaceae strains (Spearman coefficient ≤ -0.96). This new parameter may provide timely additional insight for choosing an antibiotic for a severe bacterial infection.

Identifiants

pubmed: 30716447
pii: S0924-8579(19)30020-2
doi: 10.1016/j.ijantimicag.2019.01.013
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
beta-Lactams 0

Types de publication

Journal Article

Langues

eng

Pagination

674-677

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Antoine Grillon (A)

Laboratory of Bacteriology, University Hospital of Strasbourg, Strasbourg, France. Electronic address: antoine.grillon@chru-strasbourg.fr.

Angeline Chabaud (A)

Laboratory of Bacteriology, University Hospital of Strasbourg, Strasbourg, France.

Gilles Zambardi (G)

Research and Development, bioMérieux, La Balme-les-Grottes, France.

Isabelle Caniaux (I)

Medical Affairs, bioMérieux, Marcy-l'Etoile, France.

François Jehl (F)

Laboratory of Bacteriology, University Hospital of Strasbourg, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH